<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Women&#039;s Health Line &#187; menopausal women</title>
	<atom:link href="http://www.womenhealthline.com/tag/menopausal-women/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.womenhealthline.com</link>
	<description></description>
	<lastBuildDate>Fri, 03 Feb 2012 09:23:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>HRT Therapy – Delving Into The Finer Nuances &#8211; Part II</title>
		<link>http://www.womenhealthline.com/hrt-therapy-delving-into-the-finer-nuances-part-ii/</link>
		<comments>http://www.womenhealthline.com/hrt-therapy-delving-into-the-finer-nuances-part-ii/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 09:45:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Menopause]]></category>
		<category><![CDATA[hormone replacement therapy in menopause]]></category>
		<category><![CDATA[hrt]]></category>
		<category><![CDATA[hrt for menopausal symptoms]]></category>
		<category><![CDATA[menopausal women]]></category>

		<guid isPermaLink="false">http://www.womenhealthline.com/?p=579</guid>
		<description><![CDATA[<p>HRT and related endometrial cancer risk Low-dosage vaginal oestrogens are also used in the treatment of postmenopausal women having frequent urinary tract infection and aggravating urinary symptoms after the underlying [...]]]></description>
			<content:encoded><![CDATA[<p><strong>HRT and related endometrial cancer risk</strong><br /> Low-dosage vaginal oestrogens are also used in the treatment of postmenopausal women having frequent urinary tract infection and aggravating urinary symptoms after the underlying pathology has been ruled out. There is no proof of local estrogen treatment related to any major risks. Though, when there is protracted use in cases of intact uterus, then it is advocated that an assessment of the endometrial pathology be conducted.</p>
<p>However, the inclusion of progesterone to the oestrogen therapy lowers the chances of endometrial disease, though schedules must normally contain a minimum of ten days in every menstrual cycle.</p>
<p>Postmenopausal women that have been on a course of sequential combo of oestrogen-progestogen treatment for greater than 5 years and desire to carry on with it are at a raised likelihood of endometrial carcinoma. Such women are suggested to opt for a change to a continual combo regimen that appears to present no added risk.</p>
<p>Few studies have indicated a probable rise in the number of ovarian cancer cases among those women on HRT. Though, there is a dearth of adequate proof from high-standing research to be able to conclude the effects of HRT on ovarian cancer.</p>
<p>Use of progesterone is particularly for providing protection to the endometrium. The administration of vaginal progesterone and LNG-IUS or levonorgestrel releasing intrauterine system usage appears to hold immense potential but anticipating greater definitive study for corroboration.</p>
<p><strong>HRT and related Venous Thromboembolism (VTE) risks</strong><br /> The likelihood of VTE among women starting HRT is augmented in the presence of personal past of thrombophilias, past VTE episodes and family past in 1st or 2nd degree relative. HRT must be circumvented among women with multifarious pre-existent risk elements for VTE.</p>
<p>Transdermal oestrogen are linked with lower likelihood of VTE when evaluated against oral oestrogen treatment and deemed as an effectual substitute. Lesser HRT dosages might also have lesser VTE risk as compared to higher dosages. It is suggested that when a women who is on HRT course develops DVT, then immediate cessation of HRT is applied.</p>
<p>Topical treatment has an obvious benefit of lesser occurrence of VTE and lowering dosage when dealing with urogenital symptoms.</p>
<p><strong><img class="alignleft size-full wp-image-580" style="padding: 3px;" title="Hrt and heart disease in women" src="http://www.womenhealthline.com/wp-content/uploads/2009/09/stressedFM0804_228x266.jpg" alt="HRT Therapy – Delving Into The Finer Nuances - Part II" width="228" height="266" />HRT and it effects on cognitive functioning</strong><br /> Latest randomized controlled WHIMS or Women’s Health Initiative Memory Study trial conducted on elderly women that were 65 years or more cited that HRT had no useful effect on cognitive function.</p>
<p>Additionally, HRT has not been noted to be of any major usefulness in treating Alzheimer’s disease.</p>
<p><strong>HRT and its effects on depression</strong><br /> HRT is not advisable for usage and not authorized as a primary therapy for clinically major depression or dementia. Few though not all research have revealed that HRT appears to uplift depressive moods among menopausal women.</p>
<p>Few research studies have indicated that the anti-depressants like venlafaxine, paroxetin and fluoxetine are unauthorized treatments choices for women having hot flushes and in women who are not participants for oestrogen therapy. An advantage of nearly 50% is noted in trials of several unconventional preparations recommended for vasomotor signs, even in placebo sets. Likewise, there is no believable proof to back the usage of food supplements and herbs.</p>
<p>Read more at: <a href="http://www.womenhealthline.com/hrt-therapy-delving-into-the-finer-nuances-part-i/" target="_blank">HRT Therapy – Delving Into The Finer Nuances – Part I</a></p>
<img src="http://www.womenhealthline.com/?ak_action=api_record_view&id=579&type=feed" alt="" />]]></content:encoded>
			<wfw:commentRss>http://www.womenhealthline.com/hrt-therapy-delving-into-the-finer-nuances-part-ii/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Female Sexual Dysfunction &#8211; FSD &#8211; Possible Emergent Treatments</title>
		<link>http://www.womenhealthline.com/female-sexual-dysfunction-fsd-possible-emergent-treatments/</link>
		<comments>http://www.womenhealthline.com/female-sexual-dysfunction-fsd-possible-emergent-treatments/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 09:45:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Menopause]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[breast cancer cases]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[sexual dysfunction]]></category>
		<category><![CDATA[sexual dysfunction in men and women]]></category>
		<category><![CDATA[sexual function]]></category>

		<guid isPermaLink="false">http://www.womenhealthline.com/?p=511</guid>
		<description><![CDATA[<p>Testosterone alone</p>
<p>Presently, it is advocated that testosterone treatment must be administered with concurrent oestrogen (progestogens included in those with intact uterus). A latest randomised controlled trial conducted employing transdermal testosterone [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Testosterone alone</strong></p>
<p>Presently, it is advocated that testosterone treatment must be administered with concurrent oestrogen (progestogens included in those with intact uterus). A latest randomised controlled trial conducted employing transdermal testosterone alone for post-menopausal women having less libido revealed that the use of 300microtestosterone patch caused a major surge in sexual function and lowered anguish.</p>
<p>The major side effect was undesirable hair growth. There were major apprehensions with the surfacing of three breast cancer cases cited in the active arms and none observed in the control set, however this outcome might be due to chance. There is still shortage of long-standing safety information.</p>
<p><strong>PDE5IS or Phoshodiestesterase Inhibitors</strong></p>
<p>During the course of a twelve week long trial, Sildenafil has been proven to enhance pleasure and lubrication. However, a larger multicentre trial has shown no alteration in arousal when evaluated against placebo, but there were major side-effects like headaches, flushing, rhinitis, ocular hindrance and dyspepsia. The other available PDE5IS are still under the scanner.</p>
<p><strong>Bupropion</strong></p>
<p>Sexual dysfunction could be treated by the beneficial use of the antidepressant, Bupropion. One trial has proven a rise in sexual function, but other trials have exhibited patchy outcomes. Those women with eating disorders have been noted to be at an increased risk of seizure attacks if they take bupropion.</p>
<p>Healthy sexual function is a crucial issue for menopausal women. Topical vaginal oestrogen is usually the preliminary line of treatment for atrophic vaginitis. During vaginal oestrogen therapy the following line of medication is followed.</p>
<p><strong>Cream</strong></p>
<p>17 beta-estradiol that is administered 2 to 4 gms/day for one to two weeks, then one to two grams each day for one to two weeks. For the maintenance phase – one gram per day is advised 1-3 times per week.</p>
<p>Conjugated estrogens are recommended in dosage of 0.5 to 2 grams per day.</p>
<p><img class="alignleft size-full wp-image-512" style="padding: 3px;" title="Sexual dysfunction in women" src="http://www.womenhealthline.com/wp-content/uploads/2009/09/menopause_250x251.jpg" alt="Female Sexual Dysfunction - FSD – Possible Emergent Treatments" width="205" height="205" />Oestriol – Ovestin cream, Organon : One application is advised each day for the initial few weeks that is followed by eventual lowering of dose on the basis of improvement in symptoms till a maintenance dose is attained, e.g., one application two times a week.</p>
<p><strong>Ring</strong></p>
<p>17 beta-estradiol. It has a release rate of 7.5 micrograms per day for three months. The total device contains two milligrams.</p>
<p><strong>Vaginal tablets</strong></p>
<p>17 beta-estradiol. Initially one tablet is advised for two weeks. During the maintenance phase, one tablet is recommended for two times in a week.</p>
<img src="http://www.womenhealthline.com/?ak_action=api_record_view&id=511&type=feed" alt="" />]]></content:encoded>
			<wfw:commentRss>http://www.womenhealthline.com/female-sexual-dysfunction-fsd-possible-emergent-treatments/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Charting Through Menopause – The Unconventional Way – Part I</title>
		<link>http://www.womenhealthline.com/charting-through-menopause-the-unconventional-way-part-i/</link>
		<comments>http://www.womenhealthline.com/charting-through-menopause-the-unconventional-way-part-i/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 08:45:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Menopause]]></category>
		<category><![CDATA[first symptoms of menopause]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[menopause treatment]]></category>
		<category><![CDATA[signs and symptoms of menopause]]></category>

		<guid isPermaLink="false">http://www.womenhealthline.com/?p=452</guid>
		<description><![CDATA[<p>Complementary and alternative menopausal treatments are deemed unconventional forms of medical treatments. They comprise of dietetic and herbal supplements, acupuncture therapy, chiropractic care, massage, biofeedback, homeopathy and consuming particular victuals [...]]]></description>
			<content:encoded><![CDATA[<p>Complementary and alternative <strong>menopausal treatments </strong>are deemed unconventional forms of medical treatments. They comprise of dietetic and herbal supplements, acupuncture therapy, chiropractic care, massage, biofeedback, homeopathy and consuming particular victuals that are considered to have safeguard and recuperative qualities.</p>
<p>Alternative therapy is often employed on its own, while complementary therapies are alternative course of treatments that are employed along with tradition line of treatments like drugs or surgery.</p>
<p>Menopausal women might experience succour from the niggling symptoms if they incorporated botanicals like phytoestrogens in their daily diet. Black cohosh and flaxseed are other dietary supplements that might allay menopausal symptoms.</p>
<p><strong>Botanicals -</strong> The plant-derived medicine that has since ages been employed by prehistoric tribal healers and are the basis for almost half of the locally available prescription drugs. Botanicals comprising of herbs and dietary supplements form a major part of alternative treatments.</p>
<p><strong>Efficacy of Botanicals in relieving Menopausal symptoms –</strong> Certain types of botanicals like phytoestrogens could aid in alleviating menopausal symptoms. Phytoestrogens are materials that are present in plant-derived foods which are believed to be having weak estrogen-similar effects. These might function within the body as a weak estrogen form. Certain types might aid in lowering cholesterol and have been recommended to mitigate hot flashes and profuse night sweating. Isofavones are a type of plant estrogen that could be noted in certain foods like soy produce –tofu, soy milk and soybeans.</p>
<p><strong>Black cohosh</strong> is commonly obtainable and has been touted by the North American Menopause Society as a useful short term aid (no longer than six months) in treating hot flashes, night sweating and dryness in the vagina. There are unclear safety concerns on its usage past 6 months. The side effects are noted to be quite uncommon and might lead to irritation in the stomach and intestines.</p>
<p><strong><img class="alignleft size-medium wp-image-453" style="padding: 3px;" title="Signs and symptoms of menopause" src="http://www.womenhealthline.com/wp-content/uploads/2009/09/menopause-300x300.jpg" alt="Charting Through Menopause – The Unconventional Way – Part I" width="225" height="225" />Flaxseed or linseed</strong> is another kind of phytoestrogen made up of lignans and is believed to assuage menopausal symptoms especially hot flashes, though there is hardly any scientific proof to back this claim. Additionally, certain studies have revealed that flaxseed might lower the risk of getting breast cancer in women. It is obtainable in varied forms such as whole seed, crushed up meal and seed oil. Though, only the mashed up or crushed version of flaxseed is believed to contain lignans which the body could assimilate.</p>
<p><strong>Evening primrose oil</strong> is another form of botanical that is frequently employed for the treatment of hot flashes, though there is absence of any scientific proof to back it. Feeling nauseous and diarrhoea are some side effects encountered. It is advisable to not take evening primrose oil in those women that are having other medical conditions or those that are taking particular medicines.</p>
<img src="http://www.womenhealthline.com/?ak_action=api_record_view&id=452&type=feed" alt="" />]]></content:encoded>
			<wfw:commentRss>http://www.womenhealthline.com/charting-through-menopause-the-unconventional-way-part-i/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Paying Heed To Bothersome Cancer Indicators &#8211; Part II</title>
		<link>http://www.womenhealthline.com/paying-heed-to-bothersome-cancer-indicators-part-ii/</link>
		<comments>http://www.womenhealthline.com/paying-heed-to-bothersome-cancer-indicators-part-ii/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 21:30:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Tests & Procedures]]></category>
		<category><![CDATA[cancer indicators]]></category>
		<category><![CDATA[gastro intestinal tract]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[menstrual cycle]]></category>
		<category><![CDATA[pigmentation]]></category>
		<category><![CDATA[skin growths]]></category>

		<guid isPermaLink="false">http://www.womenhealthline.com/?p=44</guid>
		<description><![CDATA[<p>Many are of the viewpoint that cancer affects only the older generation, which is partially correct but, many youngsters are also reportedly getting cancer. Certain women are as adept at [...]]]></description>
			<content:encoded><![CDATA[<p>Many are of the viewpoint that <strong>cancer </strong>affects only the older generation, which is partially correct but, many youngsters are also reportedly getting cancer. Certain <strong>women </strong>are as adept at getting into the denial phase, much similar to men, while others are still stuck in the cultural convictions that cancer is terminal and hence don’t want to venture into that territory. Though, many of the indicators might not instantaneously make a women fret about cancer, nonetheless they must be medically diagnosed to rule out any undesirable conditions.</p>
<ul>
<li style="padding-bottom:15px;">Most<strong> menstruating women</strong> are often quite ignorant in regards to spotting between their monthly cycles, while others happen to pay the least of concerns about blood loss that originates from the <strong>gastro-intestinal tract</strong>, erroneously assuming it to be their menstrual cycle. However, irregular bleeding that occurs abruptly between two period cycles, particularly if a woman has normally had regular cycles, needs to be medically scrutinised. If bleeding occurs in menopausal women, it might as well be pointing towards the presence of endometrial cancer. Blood loss from the gastro-intestinal tract may perhaps be an indicator of colorectal cancer.</li>
</ul>
<p style="padding-left: 30px;"><strong>Endometrial cancer</strong> is a widespread cancer among women with near three quarters of the women populace diagnosed with endometrial cancer have had instances of unnatural bleeding at some point of time as an early indicator.</p>
<p style="padding-left: 30px;">After taking into account the past bleeding pattern and other signs, the doctor would most likely recommend to undertake a biopsy test or an ultrasound scan.</p>
<ul>
<li style="padding-bottom:15px;"><img class="alignright size-medium wp-image-45" style="padding: 3px;" title="Cancer indicator" src="http://www.womenhealthline.com/wp-content/uploads/2009/09/si55551370-300x195.jpg" alt="Paying Heed To Bothersome Cancer Indicators - Part II" width="297" height="192" />A common awareness is to watch out for any variations in moles that are normally single or clustered brown or black coloured skin growths found all over the body. Any alterations in the appearance of moles are most likely linked to skin cancer. In addition, one must also check for any differences in the skin’s pigmentation. A sudden loss of blood from the skin’s surface or unwarranted scaling that persists for more than several weeks on end, needs to be medically diagnosed.</li>
<li style="padding-bottom:15px;">Many that experience trouble in ingesting foods quite often alter their diets in a way that grinding and chomping food is not much of a hassle, thus going in for liquid diets or foods like soups, milkshakes. However, this discomfort in ingesting food might well be a symptom of gastrointestinal cancer that might be localised in the oesophagus.</li>
</ul>
<p>During the medical exam, the doctor would take in into account the medical past and suggest a battery of tests like X-ray of the chest or tests related to the gastrointestinal tract.</p>
<p>Read more at: <a href="http://www.womenhealthline.com/paying-heed-to-bothersome-cancer-indicators-part-i/">Paying Heed To Bothersome Cancer Indicators &#8211; Part I</a></p>
<img src="http://www.womenhealthline.com/?ak_action=api_record_view&id=44&type=feed" alt="" />]]></content:encoded>
			<wfw:commentRss>http://www.womenhealthline.com/paying-heed-to-bothersome-cancer-indicators-part-ii/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Atypical Vaginal Wall Cysts</title>
		<link>http://www.womenhealthline.com/the-atypical-vaginal-wall-cysts/</link>
		<comments>http://www.womenhealthline.com/the-atypical-vaginal-wall-cysts/#comments</comments>
		<pubDate>Tue, 02 Jun 2009 17:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Urinary]]></category>
		<category><![CDATA[bladder problems]]></category>
		<category><![CDATA[cyst]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[outer vaginal cysts]]></category>
		<category><![CDATA[vaginal cysts]]></category>
		<category><![CDATA[vaginal discharge]]></category>
		<category><![CDATA[vaginal gland cyst]]></category>
		<category><![CDATA[vaginal gland cysts]]></category>

		<guid isPermaLink="false">http://www.womenhealthline.com/?p=247</guid>
		<description><![CDATA[<p>Vaginal wall cysts have been cited principally in women in their child bearing age. However, these have been additionally noted in infanthood, children and post menopausal women. The cited occurrence [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Vaginal wall cysts</strong> have been cited principally in women in their child bearing age. However, these have been additionally noted in infanthood, children and post menopausal women. The cited occurrence is one in two hundred. Certain reassessments detected epithelial cysts to be the widely prevalent vaginal cysts while there were others that cited mullerial cysts. Though they could crop up anywhere, however they are normally seen in the anterolateral vaginal wall.</p>
<p>Their size is noted to be varying between 1.4cms &#8211; 7cms. On rare occasions a symptomatic congenital cyst could be even bigger than the range just specified. Cysts that appear at the level of the cervix normally enlarge anteriorly lying in relation to the bladder and may present as cystocele. Hardly ever a large sized mullerian cyst might present as anterior enterocele. In some rare cases, the cyst may present as posterolateral wall. Additionally, the comparatively rare occurrence of daughter cyst that is totally reducible within the parent cyst is noted.</p>
<p>The rather atypical and mostly a secondary detection, the vaginal cysts have been categorised on the basis of the histology of their lining as epithelial inclusion, mullerian, mesonephric and urothelial in addition to other uncommon forms. Mullerian cysts might be symptomatic at times presenting as a noticeable or conspicuous mass, dyspareunia, voiding problem, vaginal discharge and pain.</p>
<p>Those women that suffer from this rare vaginal cyst experience problems during pregnancy due to a mass prolapsing through the introitus. The mass is noted to increase in size on straining and is totally reducible. The size of the mass however remains constant over time with no associated bowel or bladder problems.</p>
<p><img class="alignleft size-full wp-image-248" style="padding: 3px;" title="Vaginal cysts" src="http://www.womenhealthline.com/wp-content/uploads/2009/09/vaginal.jpg" alt="The Atypical Vaginal Wall Cysts" width="287" height="190" />Such women undergo caesarean section as the vaginal mass was expected to cause hindrance to delivery. In such women, the general and abdominal exams were normal. The presence of a 5 x 5 centimetres tense cystic swelling encased by vaginal mucosa is seen at the introitus in these women. Transvaginal sonography revealed normal uterus and ovaries. A computed tomography scan shows the presence of hypodense lesion of fluid intensity noted in the region of the vagina projecting through the introitus and expanding to posterior fornix with the appearance of internal septation and without any mural nodule or contrast enhancement. Though, rectum appears normal.</p>
<p>Such patients are taken up for surgical excision of the cyst under anesthesia. During the operation, the cyst wall is stripped away from the vaginal wall and the cyst removed in toto.</p>
<img src="http://www.womenhealthline.com/?ak_action=api_record_view&id=247&type=feed" alt="" />]]></content:encoded>
			<wfw:commentRss>http://www.womenhealthline.com/the-atypical-vaginal-wall-cysts/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>

